Biomerica to produce tests for ICN
This article was originally published in Clinica
Executive Summary
Biomerica is to manufacture a range of diagnostics for worldwide marketing by ICN Diagnostics, part of ICN Pharmaceuticals. The agreement covers rapid point-of-care and lab-based tests.